Vera Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VERA and other ETFs, options, and stocks.

About VERA

Vera Therapeutics, Inc. is a clinical stage biotechnical company that engages in the development and commercialization of transformative treatments for immunological diseases. Its primary product, atacicept, is a fusion protein self-administered as a subcutaneous injection that blocks both B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. 

CEO
Marshall W. Fordyce
CEOMarshall W. Fordyce
Employees
37
Employees37
Headquarters
Brisbane, California
HeadquartersBrisbane, California
Founded
2016
Founded2016
Employees
37
Employees37

VERA Key Statistics

Market cap
578.39M
Market cap578.39M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
82.65K
Average volume82.65K
High today
$22.84
High today$22.84
Low today
$20.82
Low today$20.82
Open price
$20.82
Open price$20.82
Volume
81.06K
Volume81.06K
52 Week high
$37.11
52 Week high$37.11
52 Week low
$12.29
52 Week low$12.29

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

VERA Earnings

-$12.23
-$8.15
-$4.08
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 10, Pre-Market
ActualExpected Nov 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.